Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
NCT ID:
NCT02223468
Eligibility Criteria:
Inclusion Criteria:
* First liver transplant
* Patients aged 18-70 years
* Able to consent and agree in participate in the current study for one year
Exclusion Criteria:
* Multiorgan transplantation and/or liver transplant from cardiac arrest donor and/or with ABO incompatibility.
* Uncontrolled concomitant infections (including HIV seropositivity) and/or diarrhoea, vomiting or active gastric ulcer.
* Fulminant hepatic insufficiency as first indication for liver transplant
* Hemodynamic instability prior to liver transplant.
* Recipient presenting present or previous neoplasia, except for non-metastatic basal of squamous cutaneous carcinoma or localized hepatocarcinoma with diameter \<5cm or \<3known lesions with diameter \<3cm.
* Significant comorbidity
* Breastfeeding or female patients at fertile age without negative pregnancy test and accepting the use of reliable fertility control method
* Any pretransplant antibiotherapy (oral or endovenous) or enrolled in any clinical assay
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
68 Years
Study:
NCT02223468
Study Brief:
Protocol Section:
NCT02223468